Thomas Schinecker
Vorstandsvorsitzender bei ROCHE HOLDING AG
Vermögen: 661 932 $ am 30.04.2024
Profil
Thomas Schinecker is currently the Chief Executive Officer at Roche Holding AG.
He is also the Chief Executive Officer at Roche Diagnostics Belgium NV and the Chairman at Genentech, Inc. Additionally, he holds the position of Vice President at the International Federation of Pharmaceutical Manufacturers.
In the past, he served as the Chief Executive Officer at Roche Pharmaceuticals, Inc. and Roche Diagnostics AG.
He was also the Chief Executive Officer at Roche Diagnostics Scandinavia AB and held a position on the Member-Supervisory Board at Roche Diagnostics.
GmbH.
Furthermore, he was the Head of Marketing & Sales at Roche Diagnostics Graz GmbH.
Dr. Schinecker obtained his doctorate degree from New York University in 2003.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
31.12.2022 | 2 752 ( 0,00% ) | 661 932 $ | 30.04.2024 |
Aktive Positionen von Thomas Schinecker
Unternehmen | Position | Beginn |
---|---|---|
ROCHE HOLDING AG | Vorstandsvorsitzender | 15.03.2023 |
Roche Diagnostics Belgium NV
Roche Diagnostics Belgium NV BiotechnologyHealth Technology Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The private company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker. | Vorstandsvorsitzender | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Vorsitzender | - |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | Corporate Officer/Principal | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Corporate Officer/Principal | 12.07.2023 |
Ehemalige bekannte Positionen von Thomas Schinecker
Unternehmen | Position | Ende |
---|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Vorstandsvorsitzender | 01.03.2023 |
Roche Diagnostics Scandinavia AB
Roche Diagnostics Scandinavia AB Medical/Nursing ServicesHealth Services Part of Roche Holding AG, Roche Diagnostics Scandinavia AB is a private company that provides health care services. The company is based in Solna, Sweden. Matthew Sause has been the CEO of the Swedish company since 2023. | Vorstandsvorsitzender | 01.01.2023 |
Roche Diagnostics AG
Roche Diagnostics AG Medical SpecialtiesHealth Technology Part of Novartis AG, Roche Diagnostics AG is a Swiss healthcare company committed to improving lives through innovative medicines and diagnostic tests. The private company is based in Rotkreuz, Switzerland. Roche has been a pioneer in healthcare since its founding in 1896 and has helped millions of patients worldwide. | Vorstandsvorsitzender | 01.12.2022 |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Direktor/Vorstandsmitglied | 01.01.2017 |
░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Thomas Schinecker
New York University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ROCHE HOLDING AG | Health Technology |
Private Unternehmen | 9 |
---|---|
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
Roche Diagnostics Belgium NV
Roche Diagnostics Belgium NV BiotechnologyHealth Technology Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The private company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker. | Health Technology |
Roche Diagnostics Scandinavia AB
Roche Diagnostics Scandinavia AB Medical/Nursing ServicesHealth Services Part of Roche Holding AG, Roche Diagnostics Scandinavia AB is a private company that provides health care services. The company is based in Solna, Sweden. Matthew Sause has been the CEO of the Swedish company since 2023. | Health Services |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Diagnostics AG
Roche Diagnostics AG Medical SpecialtiesHealth Technology Part of Novartis AG, Roche Diagnostics AG is a Swiss healthcare company committed to improving lives through innovative medicines and diagnostic tests. The private company is based in Rotkreuz, Switzerland. Roche has been a pioneer in healthcare since its founding in 1896 and has helped millions of patients worldwide. | Health Technology |
Roche Diagnostics Graz GmbH | |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | Health Technology |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |